Trade

with

DexCom Inc
(NASDAQ: DXCM)
AdChoices
42.00
+1.34
+3.30%
After Hours :
42.00
0.00
0.00%

Open

40.64

Previous Close

40.66

Volume (Avg)

537.75k (641.43k)

Day's Range

40.39-42.19

52Wk Range

27.10-49.83

Market Cap.

3.07B

Dividend Rate ( Yield )

-

Beta

0.46

Shares Outstanding

75.48M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 160.00M

    • Net Income

    • -29.80M

    • Market Cap.

    • 3.07B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -13.52

    • PEG (Price/Earnings Growth) Ratio

    • 25.71

    • Beta

    • 0.46

    • Forward P/E

    • 208.33

    • Price/Sales

    • 14.81

    • Price/Book Value

    • 30.77

    • Price/Cash flow

    • 303.03

      • EBITDA

      • -21.90M

      • Return on Capital %

      • -22.40

      • Return on Equity %

      • -31.53

      • Return on Assets %

      • -22.40

      • Book Value/Share

      • 1.32

      • Shares Outstanding

      • 75.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 48.67

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.20

        • Cashflow Estimate

        • 0.51

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 64.20

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 74.68

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 65.54

            • 52.83

            • Pre-Tax Margin

            • -13.52

            • 15.96

            • Net Profit Margin

            • -13.52

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 41.30

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -85.10

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.04

              • 0.62

              • Current Ratio

              • 2.96

              • 1.97

              • Quick Ratio

              • 2.53

              • 1.16

              • Interest Coverage

              • -29.11

              • 10.47

              • Leverage Ratio

              • 1.40

              • 2.38

              • Book Value/Share

              • 1.32

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -108.70

                • 35.09

                • P/E Ratio 5-Year High

                • -134.32

                • 279.76

                • P/E Ratio 5-Year Low

                • -17.61

                • 148.87

                • Price/Sales Ratio

                • 14.75

                • 3.22

                • Price/Book Value

                • 30.67

                • 4.03

                • Price/Cash Flow Ratio

                • 303.03

                • 16.69

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -31.53

                    (-)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -22.40

                    (-65.10)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -28.37

                    (-)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 7.31

                  • 2.66

                  • Asset Turnover

                  • 1.66

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -28.90M
                  Operating Margin
                  -18.06
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  303.03
                  Ownership

                  Institutional Ownership

                  96.96%

                  Top 10 Institutions

                  46.73%

                  Mutual Fund Ownership

                  61.10%

                  Float

                  97.59%

                  5% / Insider Ownership

                  2.95%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Federated Kaufmann Fund

                  •  

                    3,389,253

                  • 1.17

                  • 4.50

                  • T. Rowe Price New Horizons Fund

                  •  

                    2,594,000

                  • 36.16

                  • 3.44

                  • Fidelity® Contrafund® Fund

                  •  

                    1,968,663

                  • 4.22

                  • 2.61

                  • Artisan Small Cap Fund

                  •  

                    1,499,334

                  • -5.56

                  • 1.99

                  • Baron Small Cap Fund

                  •  

                    1,250,000

                  • 0.00

                  • 1.66

                  • Vanguard Small Cap Index

                  •  

                    1,245,421

                  • 0.41

                  • 1.65

                  • iShares Russell 2000 (AU)

                  •  

                    1,173,514

                  • -1.01

                  • 1.58

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,159,170

                  • 0.37

                  • 1.54

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    841,745

                  • -1.52

                  • 1.12

                  • ASTON/TAMRO Small Cap Fund

                  •  

                    824,723

                  • -18.88

                  • 1.09

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    5,334,604

                  • +46.68%

                  • 7.08

                  • Federated Global Inv Mgmt Corp

                  •  

                    4,446,933

                  • +888.21%

                  • 5.90

                  • Vanguard Group, Inc.

                  •  

                    4,346,111

                  • -1.49%

                  • 5.76

                  • Fidelity Management and Research Company

                  •  

                    4,164,634

                  • -0.93%

                  • 5.52

                  • T. Rowe Price Associates, Inc.

                  •  

                    3,998,300

                  • +42.13%

                  • 5.30

                  • Gilder Gagnon Howe & CO LLC

                  •  

                    3,939,999

                  • -0.79%

                  • 5.23

                  • Artisan Partners Limited Partnership

                  •  

                    2,809,111

                  • -2.33%

                  • 3.73

                  • Frontier Capital Management CO Inc

                  •  

                    2,107,205

                  • -6.28%

                  • 2.79

                  • Waddell & Reed Investment Management Co

                  •  

                    2,095,481

                  • +3.63%

                  • 2.78

                  • Franklin Advisers, Inc.

                  •  

                    1,992,996

                  • +71.63%

                  • 2.64

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  The majority of its product revenue comes from sales of its SEVEN PLUS ambulatory continuous glucose monitoring system. The Company’s SEVEN PLUS and G4 PLATINUM systems are more invasive than current self-monitored glucose testing sy...morestems, including single-point finger stick devices, and patients may be unwilling to insert a sensor in their body, especially if their current diabetes management involves no more than two finger sticks per day. Moreover, patients may not perceive the benefits of continuous glucose monitoring and may be unwilling to change their current treatment regimens. As compared to the SEVEN PLUS, the G4 PLATINUM offers additional user interface and algorithm enhancements that are intended to make its glucose monitoring function more accurate especially in the hypoglycemic range. ...moreTo address the in-hospital patient population, it entered into an exclusive agreement with Edwards to develop jointly and market a specific product platform for the in-hospital glucose monitoring market, with an initial focus on the development of an intravenous sensor specifically for the critical care market. Its products also shows how fast the body’s glucose levels are changing. It is designed to help avoid highs and lows and to help keep the glucose between the lines of the target zones. Its competitors include Roche Disetronic, Roche Diagnostics, LifeScan, Inc, Johnson & Johnson, the MediSense and Abbott Laboratories, and Bayer Corporatio. Its products are medical devices subject to extensive and ongoing regulation by the FDA and regulatory bodies in other countries.lessless

                  Key People

                  Terrance H. Gregg

                  CEO/Director

                  Dr. Jonathan T. Lord,M.D.

                  Chairman of the Board/Director

                  Jess Roper

                  CFO/Chief Accounting Officer/Vice President

                  Steven R. Pacelli

                  Executive VP, Divisional

                  Kevin R. Sayer,C.P.A.

                  Director/President/COO

                  • DexCom Inc

                  • 6340 Sequence Drive

                  • San Diego, CA 92121

                  • USA.Map

                  • Phone: +1 855 200-0200

                  • Fax: -

                  • dexcom.com

                  Incorporated

                  1999

                  Employees

                  765

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: